In combination with azacitidine or decitabine, or small-dose cytarabine in freshly diagnosed AML aged ≥ seventy five years or with co-morbidities that preclude the use of intensive induction chemotherapy A lot of things arrive into Participate in When contemplating unique survival costs for leukemia. Most cancers staging is A serious https://directivepublications.org/journal-of-leukemia-research/